Melanoma of Unknown Primary — knowledge graph · CancerIndex

Knowledge graph · Cancer

Melanoma of Unknown Primary

histology

Identifier: CI-CAN-00003304
Entity page: /cancer/melanoma-of-unknown-primary ↗
Edges: 13

Neighbours: 5 drugs8 trials
Drawn: 13 of 13 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Melanoma of Unknown Primary investigated in trials for …INVESTIGATED_IN_TRIALSderived5 of 5
→ investigated in trials for	Ipilimumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants	—	—	Melanoma of Unknown Primary	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Pembrolizumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants

Melanoma of Unknown Primary studied in …STUDIED_INderived8 of 8
→ studied in	NCT04708418Phase 2 · active not recruiting A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT01274338Phase 3 · active not recruiting Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT04221438Phase 2 · terminated Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT05341349Phase 1 · terminated Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT02858869Phase 1 · completed Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT03033576Phase 2 · completed Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →
→ studied in	NCT02129075Phase 2 · completed A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (3 active)	—	—	Melanoma of Unknown Primary	1	Observed	clinicaltrials	graph →